The Biology and Disease Human Proteome Project (B/D-HPP) Annual Report 2017-2018

Total Page:16

File Type:pdf, Size:1020Kb

The Biology and Disease Human Proteome Project (B/D-HPP) Annual Report 2017-2018 The Biology and Disease Human Proteome Project (B/D-HPP) Annual report 2017-2018 Submitted by Fernando Corrales and Ileana Cristea on behalf of all members and liaisons of the B/D-HPP Executive committee 1 The Biology and Disease Human Proteome Project (B/D-HPP) Annual report 2017-2018 1. Overview and expansion The Biology and Disease-driven Human Proteome Project (B/D-HPP) is focused to support the use of state-of- the-art proteomic methods to characterize and quantify proteins for in-depth understanding of the molecular mechanisms of biological processes and human disease across life sciences. The B/D-HPP is truly a grass root initiative where groups of individual come together globally to address key issues. One goal of the B/D-HPP is to broaden the impact of proteomics to the broader community based on organ and disease areas. A second goal is to develop popular proteins within the B/D-HPP in order to prioritize protein targets that are highly relevant to each particular field to deliver relevant assays for the measurement of these selected targets and to disseminate and make publicly accessible the information and tools generated. At the last International HUPO in Dublin, there were 19 B/D-HPP initiatives with 3 closely related HPP resource pillars. It is from these initiatives that the chairs and the B/D-HPP create 6 main sessions for the international HUPO meeting 2017. These and other groups also have a chance to present and catch up with each other on Sunday and Thursday workshops hosted HPP. An additional effort of the B/D-HPP is to encourage and support the scientific career development of the early career researchers among the HUPO community. In this sense the initiative is strongly contributing to the activities of the early career researchers helping them to create opportunities to present their work at international HUPO congresses (e.g. the ECR manuscript competition) or to interact with more senior HUPO scientists (e.g. the ECR mentoring day). The organization is Fernando Corrales, chair and Ileana Cristea (co-chair) with the most amazing executive committee consisting of Jennifer Van Eyk (past-chair), Gil Omenn (Ex officio), Hui Zhang, Eric Deutsch, Pengyuan Yang, Tadashi Yamamoto, Sanjeeva Srivastava, Paola Roncada and Michelle Hill, Ferdinando Cerciello (ECR representative) and Mark Baker (HPP Chair). 1.a. B/D HPP initiatives activity this year. According to the procedure established last year, we sent out a questionnaire to determine the viability and work being carried out by the various initiatives. The aims were: 1. To update the information about the initiatives on the B/D-HPP initiative page of the HUPO website. We would like to have an updated and attractive picture of the B/D group aims, activity and achievements to facilitate cross interactions with other HPP groups and to attract additional partners from the scientific community. 2. To compile the collected information in a B/D-HPP annual report. That will provide a global view of the B/D-HPP as a whole and will highlight our strengths. 3. To explore the willingness to participate in the HUPO Congress. This is the main HUPO activity and the participation of the B/D groups is highly encouraged by submitting abstracts to the HPP session topics, active inputs in the Sunday and Thursday programs on popular/priority proteins, PTMs, etc. 5. To explore the willingness to prepare manuscripts for the JPR Special Issue. To find new ways of interaction across B/D and C-HPP groups. Results from the questionnaire 2018 Questionnaire B/D HPP An international collaborative project that deals with mapping, annotating and characterizing the proteome using proteomics technologies in its relation to human biology and/or diseases. B/D-HPP provides a framework for the coordination of 19 initiatives that integrate about 50 multi-national research groups. 2 B/D HPP Questionnaire items 1-4 B/D HPP Questionnaire item 6 1. Please state the name of your initiative, name and email of chair and co-chairs, starting date of your B/D initiative and any additional information: 6. Are you currently doing research on popular/priority proteins? 2. What are your main aims? 2.a. Brief statement: Yes: 2.b. Some of the current lines of work include (fill in for your initiative): 80 If not, would you be willing to? 10 2.c. Main achievements in 2017: 70 3. Any related documents you’d like to link? 9 3.a Websites and links (fill in for your initiative): 60 Yes No In the future 8 HBPP Cancer FAN 3.b Papers (fill in for your initiative) 7 3.b.1 Papers published in collaboration within the initiative 50 * CVD HIPP * 6 3.b.2 List Top 5 papers for 2017 40 * HKUPP * 3.c Congresses in 2017? (Committees, lectures… )(fill in for your initiative) * EyeOme 5 30 * 3.c.1 Participation in proteomics meetings in 2017? Liver 4 3.c.2 Participation in congresses organized by other biomedical or clinical associations 20 Mitochondria 3 3.d Other documents 4. Educational and dissemination activity (Courses, workshops, summer schools, etc) in 2017 10 PediOme 2 Plasma 1 0 s s s RAD r e e 0 i e s t s i p r Yes No In the future v a r i t p g c n d a o • e Updated information for each initiative: leadership, participatin c n h • Protein lists available from peptide atlas (https://db.systemsbiology.net/sbeams/cgi/ l o s i i a l t n a laboratories, main aims, plans and activity. Valuable information to b o u n i i PeptideAtlas/proteinList?protein_list_id=45 ). t P a m n keep updated the B/D HPP web page. e r s e • s Five papers already published (EyeOme, Liver and RAD). i t d n I • In addition to the 72 papers (top 5 published by initiatives’ labs) / l a • Two published tools for selecting popular proteins from the literature n o reported by the 13 initiatives answering the questionnaire, 17 were i t a Data-Driven Approach To Determine Popular Proteins for Targeted Proteomics Translation of Six Organ Systems. c collaborative efforts of the participating laboratories. u d Lam MP, Venkatraman V1, Xing Y, Lau E, Cao Q2, Ng DC, Su AI3, Ge J2, Van Eyk JE1, Ping P. • Participation in 44 international congressess, 20 on proteomics and E J Proteome Res. 2016 Nov 4;15(11):4126-4134. Epub 2016 Jul 19. 24on other biomedical, clinical disciplines. *Collaborative publications Systematic Protein Prioritization for Targeted Proteomics Studies through Literature Mining. • Organisation of 30 educational and dissemination related activities. **Proteomics Yu KH, Lee TM, Wang CS, Chen YJ, Ré C, Kou SC, Chiang JH, Kohane IS, Snyder M. ***Biomediacal/clinical J Proteome Res. 2018 Apr 6;17(4):1383-1396. doi: 10.1021/acs.jproteome.7b00772. Epub 2018 Mar 15. B/D HPP Questionnaire item 7 B/D HPP Questionnaire item 8 8. During the analysis of your specific and perhaps unique samples that might be of great value to identify missing proteins. 7. Activities and meetings planned for 2018 • Would you be willing to share raw MS data sets for reanalysis in collaboration with other HPP initiatives? Meeting participation/organization • Would you be willing to share samples? Like what? Initiative HUPO/HPP Others 11 Cancer 1 10 • Would you be willing to run samples from other teams? CVD 1 9 EyeOme 8 Initiative Data Samples Run samples 14 FAN 5 7 Cancer 1 1 1 HBPP 1 3 CVD 1 1 1 12 6 HIPP 1 EyeOme 1 0 0 5 Liver 2 FAN 1 1 1 10 4 HBPP 1 0 0 Mitochondria 1 1 8 3 HIPP IMOP Liver 1 0 1 2 PediOme 1 Mitochondria 1 0 1 6 Plasma 1 1 1 IMOP 1 0 1 4 RAD 1 1 0 PediOme 1 1 1 HUPO/HPP Others Plasma 1 0 1 2 RAD 1 1 1 KUHPP 1 0 1 0 12 5 10 • Some initiatives (HBPP, CVD, Liver, RAD) report activities including setting up Data Samples Run samples analytical methods (for popular proteins in some cases) and preparation of • Data sharing if published or under collaboration publications (new data and reviews). • Type of sample not indicated but in the case of RAD (serum). Difficulties due to • All initiatives attending the HUPO meeting in Orlando were planning to present their regulatory issues work but this has not being included in the agenda. • Availability to run limited number of samples according to capacity. B/D HPP Questionnaire item 10 10. Would your initiative be willing to prepare a data-driven manuscript based around your initiative for the HPP special issue in Journal of Proteome Research? Manuscripts are due by 31 May 2018 Initiative HPP 6 session track Sunday HPP Pis Thursday HPP Early morning Cancer 1 1* 1 1* CVD 1 1 1 1 EyeOme 1 1 1 1 FAN 1 1 1 1 HBPP 1 1 1 1 HIPP 1 0 1 0 Liver 1 1 1 1 Mitochondria 0 0 0 0 IMOP 0 0 0 0 PediOme 1 1 1 1 Plasma 1 1 1 1 RAD 1 1 0 1 KUHPP 1 1 1 1 11 9 10 9 2. Contributions to HUPO Orlando 2018. This year the initiative is involved at International HUPO Sunday: HPP Investigators Meeting Sunday-Wednesday Bioinformatics Hub Monday – Wednesday: B/D-HPP Scientific Track comprising 6 sessions ECR manuscript competition Clinical Fellow Travel Award Thursday: HPP Strategic Workshop 3. Outreach by B/D-HPP to the proteomics and broader scientific community 3.a.
Recommended publications
  • Bioinformatic Analysis of Structure and Function of LIM Domains of Human Zyxin Family Proteins
    International Journal of Molecular Sciences Article Bioinformatic Analysis of Structure and Function of LIM Domains of Human Zyxin Family Proteins M. Quadir Siddiqui 1,† , Maulik D. Badmalia 1,† and Trushar R. Patel 1,2,3,* 1 Alberta RNA Research and Training Institute, Department of Chemistry and Biochemistry, University of Lethbridge, 4401 University Drive, Lethbridge, AB T1K 3M4, Canada; [email protected] (M.Q.S.); [email protected] (M.D.B.) 2 Department of Microbiology, Immunology and Infectious Disease, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive, Calgary, AB T2N 4N1, Canada 3 Li Ka Shing Institute of Virology, University of Alberta, Edmonton, AB T6G 2E1, Canada * Correspondence: [email protected] † These authors contributed equally to the work. Abstract: Members of the human Zyxin family are LIM domain-containing proteins that perform critical cellular functions and are indispensable for cellular integrity. Despite their importance, not much is known about their structure, functions, interactions and dynamics. To provide insights into these, we used a set of in-silico tools and databases and analyzed their amino acid sequence, phylogeny, post-translational modifications, structure-dynamics, molecular interactions, and func- tions. Our analysis revealed that zyxin members are ohnologs. Presence of a conserved nuclear export signal composed of LxxLxL/LxxxLxL consensus sequence, as well as a possible nuclear localization signal, suggesting that Zyxin family members may have nuclear and cytoplasmic roles. The molecular modeling and structural analysis indicated that Zyxin family LIM domains share Citation: Siddiqui, M.Q.; Badmalia, similarities with transcriptional regulators and have positively charged electrostatic patches, which M.D.; Patel, T.R.
    [Show full text]
  • Phylogenomic Analysis of the Chlamydomonas Genome Unmasks Proteins Potentially Involved in Photosynthetic Function and Regulation
    Photosynth Res DOI 10.1007/s11120-010-9555-7 REVIEW Phylogenomic analysis of the Chlamydomonas genome unmasks proteins potentially involved in photosynthetic function and regulation Arthur R. Grossman • Steven J. Karpowicz • Mark Heinnickel • David Dewez • Blaise Hamel • Rachel Dent • Krishna K. Niyogi • Xenie Johnson • Jean Alric • Francis-Andre´ Wollman • Huiying Li • Sabeeha S. Merchant Received: 11 February 2010 / Accepted: 16 April 2010 Ó The Author(s) 2010. This article is published with open access at Springerlink.com Abstract Chlamydomonas reinhardtii, a unicellular green performed to identify proteins encoded on the Chlamydo- alga, has been exploited as a reference organism for iden- monas genome which were likely involved in chloroplast tifying proteins and activities associated with the photo- functions (or specifically associated with the green algal synthetic apparatus and the functioning of chloroplasts. lineage); this set of proteins has been designated the Recently, the full genome sequence of Chlamydomonas GreenCut. Further analyses of those GreenCut proteins with was generated and a set of gene models, representing all uncharacterized functions and the generation of mutant genes on the genome, was developed. Using these gene strains aberrant for these proteins are beginning to unmask models, and gene models developed for the genomes of new layers of functionality/regulation that are integrated other organisms, a phylogenomic, comparative analysis was into the workings of the photosynthetic apparatus. Keywords Chlamydomonas Á GreenCut Á Chloroplast Á Phylogenomics Á Regulation A. R. Grossman (&) Á M. Heinnickel Á D. Dewez Á B. Hamel Department of Plant Biology, Carnegie Institution for Science, 260 Panama Street, Stanford, CA 94305, USA Introduction e-mail: [email protected] Chlamydomonas reinhardtii as a reference organism S.
    [Show full text]
  • An Emerging Field for the Structural Analysis of Proteins on the Proteomic Scale † ‡ ‡ ‡ § ‡ ∥ Upneet Kaur, He Meng, Fang Lui, Renze Ma, Ryenne N
    Perspective Cite This: J. Proteome Res. 2018, 17, 3614−3627 pubs.acs.org/jpr Proteome-Wide Structural Biology: An Emerging Field for the Structural Analysis of Proteins on the Proteomic Scale † ‡ ‡ ‡ § ‡ ∥ Upneet Kaur, He Meng, Fang Lui, Renze Ma, Ryenne N. Ogburn, , Julia H. R. Johnson, , ‡ † Michael C. Fitzgerald,*, and Lisa M. Jones*, ‡ Department of Chemistry, Duke University, Durham, North Carolina 27708-0346, United States † Department of Pharmaceutical Sciences, University of Maryland, Baltimore, Maryland 21201, United States ABSTRACT: Over the past decade, a suite of new mass- spectrometry-based proteomics methods has been developed that now enables the conformational properties of proteins and protein− ligand complexes to be studied in complex biological mixtures, from cell lysates to intact cells. Highlighted here are seven of the techniques in this new toolbox. These techniques include chemical cross-linking (XL−MS), hydroxyl radical footprinting (HRF), Drug Affinity Responsive Target Stability (DARTS), Limited Proteolysis (LiP), Pulse Proteolysis (PP), Stability of Proteins from Rates of Oxidation (SPROX), and Thermal Proteome Profiling (TPP). The above techniques all rely on conventional bottom-up proteomics strategies for peptide sequencing and protein identification. However, they have required the development of unconventional proteomic data analysis strategies. Discussed here are the current technical challenges associated with these different data analysis strategies as well as the relative analytical capabilities of the different techniques. The new biophysical capabilities that the above techniques bring to bear on proteomic research are also highlighted in the context of several different application areas in which these techniques have been used, including the study of protein ligand binding interactions (e.g., protein target discovery studies and protein interaction network analyses) and the characterization of biological states.
    [Show full text]
  • Static Retention of the Lumenal Monotopic Membrane Protein Torsina in the Endoplasmic Reticulum
    The EMBO Journal (2011) 30, 3217–3231 | & 2011 European Molecular Biology Organization | All Rights Reserved 0261-4189/11 www.embojournal.org TTHEH E EEMBOMBO JJOURNALOURN AL Static retention of the lumenal monotopic membrane protein torsinA in the endoplasmic reticulum Abigail B Vander Heyden1, despite the fact that it has been a decade since the protein was Teresa V Naismith1, Erik L Snapp2 and first described and linked to dystonia (Breakefield et al, Phyllis I Hanson1,* 2008). Based on its membership in the AAA þ family of ATPases (Ozelius et al, 1997; Hanson and Whiteheart, 2005), 1Department of Cell Biology and Physiology, Washington University School of Medicine, St Louis, MO, USA and 2Department of Anatomy it is likely that torsinA disassembles or changes the confor- and Structural Biology, Albert Einstein College of Medicine, Bronx, mation of a protein or protein complex in the ER or NE. The NY, USA DE mutation is thought to compromise this function (Dang et al, 2005; Goodchild et al, 2005). TorsinA is a membrane-associated enzyme in the endo- TorsinA is targeted to the ER lumen by an N-terminal plasmic reticulum (ER) lumen that is mutated in DYT1 signal peptide. Analyses of torsinA’s subcellular localization, dystonia. How it remains in the ER has been unclear. We processing, and glycosylation show that the signal peptide is report that a hydrophobic N-terminal domain (NTD) di- cleaved and the mature protein resides in the lumen of the ER rects static retention of torsinA within the ER by excluding (Kustedjo et al, 2000; Hewett et al, 2003; Liu et al, 2003), it from ER exit sites, as has been previously reported for where it is a stable protein (Gordon and Gonzalez-Alegre, short transmembrane domains (TMDs).
    [Show full text]
  • PROTEOMICS the Human Proteome Takes the Spotlight
    RESEARCH HIGHLIGHTS PROTEOMICS The human proteome takes the spotlight Two papers report mass spectrometry– big data. “We then thought, include some surpris- based draft maps of the human proteome ‘What is a potentially good ing findings. For example, and provide broadly accessible resources. illustration for the utility Kuster’s team found protein For years, members of the proteomics of such a database?’” says evidence for 430 long inter- community have been trying to garner sup- Kuster. “We very quickly genic noncoding RNAs, port for a large-scale project to exhaustively got to the idea, ‘Why don’t which have been thought map the normal human proteome, including we try to put together the not to be translated into pro- identifying all post-translational modifica- human proteome?’” tein. Pandey’s team refined tions and protein-protein interactions and The two groups took the annotations of 808 genes providing targeted mass spectrometry assays slightly different strategies and also found evidence and antibodies for all human proteins. But a towards this common goal. for the translation of many Nik Spencer/Nature Publishing Group Publishing Nik Spencer/Nature lack of consensus on how to exactly define Pandey’s lab examined 30 noncoding RNAs and pseu- Two groups provide mass the proteome, how to carry out such a mis- normal tissues, including spectrometry evidence for dogenes. sion and whether the technology is ready has adult and fetal tissues, as ~90% of the human proteome. Obtaining evidence for not so far convinced any funding agencies to well as primary hematopoi- the last roughly 10% of pro- fund on such an ambitious project.
    [Show full text]
  • A New Census of Protein Tandem Repeats and Their Relationship with Intrinsic Disorder
    G C A T T A C G G C A T genes Article A New Census of Protein Tandem Repeats and Their Relationship with Intrinsic Disorder Matteo Delucchi 1,2 , Elke Schaper 1,2,† , Oxana Sachenkova 3,‡, Arne Elofsson 3 and Maria Anisimova 1,2,* 1 ZHAW Life Sciences und Facility Management, Applied Computational Genomics, 8820 Wädenswil, Switzerland; [email protected] 2 Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland 3 Science of Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, 106 91 Stockholm, Sweden * Correspondence: [email protected]; Tel.: +41-(0)58-934-5882 † Present address: Carbon Delta AG, 8002 Zürich, Switzerland. ‡ Present address: Vildly AB, 385 31 Kalmar, Sweden. Received: 9 March 2020; Accepted: 1 April 2020; Published: 9 April 2020 Abstract: Protein tandem repeats (TRs) are often associated with immunity-related functions and diseases. Since that last census of protein TRs in 1999, the number of curated proteins increased more than seven-fold and new TR prediction methods were published. TRs appear to be enriched with intrinsic disorder and vice versa. The significance and the biological reasons for this association are unknown. Here, we characterize protein TRs across all kingdoms of life and their overlap with intrinsic disorder in unprecedented detail. Using state-of-the-art prediction methods, we estimate that 50.9% of proteins contain at least one TR, often located at the sequence flanks. Positive linear correlation between the proportion of TRs and the protein length was observed universally, with Eukaryotes in general having more TRs, but when the difference in length is taken into account the difference is quite small.
    [Show full text]
  • PA28: New Insights on an Ancient Proteasome Activator
    biomolecules Review PA28γ: New Insights on an Ancient Proteasome Activator Paolo Cascio Department of Veterinary Sciences, University of Turin, Largo P. Braccini 2, 10095 Grugliasco, Italy; [email protected] Abstract: PA28 (also known as 11S, REG or PSME) is a family of proteasome regulators whose members are widely present in many of the eukaryotic supergroups. In jawed vertebrates they are represented by three paralogs, PA28α, PA28β, and PA28γ, which assemble as heptameric hetero (PA28αβ) or homo (PA28γ) rings on one or both extremities of the 20S proteasome cylindrical structure. While they share high sequence and structural similarities, the three isoforms significantly differ in terms of their biochemical and biological properties. In fact, PA28α and PA28β seem to have appeared more recently and to have evolved very rapidly to perform new functions that are specifically aimed at optimizing the process of MHC class I antigen presentation. In line with this, PA28αβ favors release of peptide products by proteasomes and is particularly suited to support adaptive immune responses without, however, affecting hydrolysis rates of protein substrates. On the contrary, PA28γ seems to be a slow-evolving gene that is most similar to the common ancestor of the PA28 activators family, and very likely retains its original functions. Notably, PA28γ has a prevalent nuclear localization and is involved in the regulation of several essential cellular processes including cell growth and proliferation, apoptosis, chromatin structure and organization, and response to DNA damage. In striking contrast with the activity of PA28αβ, most of these diverse biological functions of PA28γ seem to depend on its ability to markedly enhance degradation rates of regulatory protein by 20S proteasome.
    [Show full text]
  • Bioinformatics: a Practical Guide to the Analysis of Genes and Proteins, Second Edition Andreas D
    BIOINFORMATICS A Practical Guide to the Analysis of Genes and Proteins SECOND EDITION Andreas D. Baxevanis Genome Technology Branch National Human Genome Research Institute National Institutes of Health Bethesda, Maryland USA B. F. Francis Ouellette Centre for Molecular Medicine and Therapeutics Children’s and Women’s Health Centre of British Columbia University of British Columbia Vancouver, British Columbia Canada A JOHN WILEY & SONS, INC., PUBLICATION New York • Chichester • Weinheim • Brisbane • Singapore • Toronto BIOINFORMATICS SECOND EDITION METHODS OF BIOCHEMICAL ANALYSIS Volume 43 BIOINFORMATICS A Practical Guide to the Analysis of Genes and Proteins SECOND EDITION Andreas D. Baxevanis Genome Technology Branch National Human Genome Research Institute National Institutes of Health Bethesda, Maryland USA B. F. Francis Ouellette Centre for Molecular Medicine and Therapeutics Children’s and Women’s Health Centre of British Columbia University of British Columbia Vancouver, British Columbia Canada A JOHN WILEY & SONS, INC., PUBLICATION New York • Chichester • Weinheim • Brisbane • Singapore • Toronto Designations used by companies to distinguish their products are often claimed as trademarks. In all instances where John Wiley & Sons, Inc., is aware of a claim, the product names appear in initial capital or ALL CAPITAL LETTERS. Readers, however, should contact the appropriate companies for more complete information regarding trademarks and registration. Copyright ᭧ 2001 by John Wiley & Sons, Inc. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic or mechanical, including uploading, downloading, printing, decompiling, recording or otherwise, except as permitted under Sections 107 or 108 of the 1976 United States Copyright Act, without the prior written permission of the Publisher.
    [Show full text]
  • Proteomic Analysis of Monolayer-Integrated Proteins on Lipid Droplets Identifies Amphipathic Interfacial Α-Helical Membrane Anchors
    Proteomic analysis of monolayer-integrated proteins on lipid droplets identifies amphipathic interfacial α-helical membrane anchors Camille I. Patakia, João Rodriguesb, Lichao Zhangc, Junyang Qiand, Bradley Efrond, Trevor Hastied, Joshua E. Eliasc, Michael Levittb, and Ron R. Kopitoe,1 aDepartment of Biochemistry, Stanford University, Stanford, CA 94305; bDepartment of Structural Biology, Stanford University, Stanford, CA 94305; cDepartment of Chemical and Systems Biology, Stanford University, Stanford, CA 94305; dDepartment of Statistics, Stanford University, Stanford, CA 94305; and eDepartment of Biology, Stanford University, Stanford, CA 94305 Edited by Jennifer Lippincott-Schwartz, Howard Hughes Medical Institute, Ashburn, VA, and approved July 23, 2018 (received for review May 9, 2018) Despite not spanning phospholipid bilayers, monotopic integral The first step in understanding the structural diversity of proteins (MIPs) play critical roles in organizing biochemical reac- monotopic HMDs is to identify a sufficiently large set of proteins tions on membrane surfaces. Defining the structural basis by with unequivocal monotopic topology. In this study, we exploited which these proteins are anchored to membranes has been the fact that lipid droplets (LDs) are enveloped by phospholipid hampered by the paucity of unambiguously identified MIPs and a monolayers that separate a highly hydrophobic lipid core from lack of computational tools that accurately distinguish monolayer- the aqueous cytoplasm (8). Because TMDs are flanked on both integrating motifs from bilayer-spanning transmembrane domains ends by soluble, hydrophilic domains, bilayer-spanning proteins (TMDs). We used quantitative proteomics and statistical modeling are strongly disfavored from integrating into the monolayer to identify 87 high-confidence candidate MIPs in lipid droplets, membranes of LDs.
    [Show full text]
  • Structural Insights Into Substrate Recognition and Processing by the 20S Proteasome
    biomolecules Review Structural Insights into Substrate Recognition and Processing by the 20S Proteasome Indrajit Sahu * and Michael H. Glickman * Faculty of Biology, Technion-Israel Institute of Technology, 32000 Haifa, Israel * Correspondence: [email protected] (I.S.); [email protected] (M.H.G.); Tel.: +972-0586747499 (I.S.); +972-4-829-4552 (M.H.G.) Abstract: Four decades of proteasome research have yielded extensive information on ubiquitin- dependent proteolysis. The archetype of proteasomes is a 20S barrel-shaped complex that does not rely on ubiquitin as a degradation signal but can degrade substrates with a considerable unstructured stretch. Since roughly half of all proteasomes in most eukaryotic cells are free 20S complexes, ubiquitin-independent protein degradation may coexist with ubiquitin-dependent degradation by the highly regulated 26S proteasome. This article reviews recent advances in our understanding of the biochemical and structural features that underlie the proteolytic mechanism of 20S proteasomes. The two outer α-rings of 20S proteasomes provide a number of potential docking sites for loosely folded polypeptides. The binding of a substrate can induce asymmetric conformational changes, trigger gate opening, and initiate its own degradation through a protease-driven translocation mechanism. Consequently, the substrate translocates through two additional narrow apertures augmented by the β-catalytic active sites. The overall pulling force through the two annuli results in a protease-like unfolding of the substrate and subsequent proteolysis in the catalytic chamber. Although both proteasomes contain identical β-catalytic active sites, the differential translocation mechanisms yield distinct peptide products. Nonoverlapping substrate repertoires and product outcomes rationalize cohabitation of both proteasome complexes in cells.
    [Show full text]
  • Glossary of Terms
    GLOSSARY OF TERMS Table of Contents A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z A Amino acids: any of a class of 20 molecules that are combined to form proteins in living things. The sequence of amino acids in a protein and hence protein function are determined by the genetic code. From http://www.geneticalliance.org.uk/glossary.htm#C • The building blocks of proteins, there are 20 different amino acids. From https://www.yourgenome.org/glossary/amino-acid Antisense: Antisense nucleotides are strings of RNA or DNA that are complementary to "sense" strands of nucleotides. They bind to and inactivate these sense strands. They have been used in research, and may become useful for therapy of certain diseases (See Gene silencing). From http://www.encyclopedia.com/topic/Antisense_DNA.aspx. Antisense and RNA interference are referred as gene knockdown technologies: the transcription of the gene is unaffected; however, gene expression, i.e. protein synthesis (translation), is lost because messenger RNA molecules become unstable or inaccessible. Furthermore, RNA interference is based on naturally occurring phenomenon known as Post-Transcriptional Gene Silencing. From http://www.ncbi.nlm.nih.gov/probe/docs/applsilencing/ B Biobank: A biobank is a large, organised collection of samples, usually human, used for research. Biobanks catalogue and store samples using genetic, clinical, and other characteristics such as age, gender, blood type, and ethnicity. Some samples are also categorised according to environmental factors, such as whether the donor had been exposed to some substance that can affect health.
    [Show full text]
  • A Draft Map of the Human Proteome
    ARTICLE doi:10.1038/nature13302 A draft map of the human proteome Min-Sik Kim1,2, Sneha M. Pinto3, Derese Getnet1,4, Raja Sekhar Nirujogi3, Srikanth S. Manda3, Raghothama Chaerkady1,2, Anil K. Madugundu3, Dhanashree S. Kelkar3, Ruth Isserlin5, Shobhit Jain5, Joji K. Thomas3, Babylakshmi Muthusamy3, Pamela Leal-Rojas1,6, Praveen Kumar3, Nandini A. Sahasrabuddhe3, Lavanya Balakrishnan3, Jayshree Advani3, Bijesh George3, Santosh Renuse3, Lakshmi Dhevi N. Selvan3, Arun H. Patil3, Vishalakshi Nanjappa3, Aneesha Radhakrishnan3, Samarjeet Prasad1, Tejaswini Subbannayya3, Rajesh Raju3, Manish Kumar3, Sreelakshmi K. Sreenivasamurthy3, Arivusudar Marimuthu3, Gajanan J. Sathe3, Sandip Chavan3, Keshava K. Datta3, Yashwanth Subbannayya3, Apeksha Sahu3, Soujanya D. Yelamanchi3, Savita Jayaram3, Pavithra Rajagopalan3, Jyoti Sharma3, Krishna R. Murthy3, Nazia Syed3, Renu Goel3, Aafaque A. Khan3, Sartaj Ahmad3, Gourav Dey3, Keshav Mudgal7, Aditi Chatterjee3, Tai-Chung Huang1, Jun Zhong1, Xinyan Wu1,2, Patrick G. Shaw1, Donald Freed1, Muhammad S. Zahari2, Kanchan K. Mukherjee8, Subramanian Shankar9, Anita Mahadevan10,11, Henry Lam12, Christopher J. Mitchell1, Susarla Krishna Shankar10,11, Parthasarathy Satishchandra13, John T. Schroeder14, Ravi Sirdeshmukh3, Anirban Maitra15,16, Steven D. Leach1,17, Charles G. Drake16,18, Marc K. Halushka15, T. S. Keshava Prasad3, Ralph H. Hruban15,16, Candace L. Kerr19{, Gary D. Bader5, Christine A. Iacobuzio-Donahue15,16,17, Harsha Gowda3 & Akhilesh Pandey1,2,3,4,15,16,20 The availability of human genome sequence has transformed biomedical research over the past decade. However, an equiv- alent map for the human proteome with direct measurements of proteins and peptides does not exist yet. Here we present a draft map of the human proteome using high-resolution Fourier-transform mass spectrometry.
    [Show full text]